Beaconlight Capital’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
WRF
FLAM
AIM
CS
Beaconlight Capital's CDNA Position: Q3 2020 in Review
Beaconlight Capital sold out of CareDx (CDNA) in Q3 2020, closing a stake of 125,403 shares — an estimated $4.44M sold.
Beaconlight Capital first reported a position in CDNA in Q3 2018 and held it in 5 quarters. The position peaked at $7.45M in Q3 2018. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.
- Beaconlight Capital reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
- Beaconlight Capital sold 125,403 CareDx shares in Q3 2020, an estimated $4.44M.
- Beaconlight Capital first reported a position in CareDx in Q3 2018 and held it in 5 quarters.
- Beaconlight Capital's CareDx position peaked at $7.45M in Q3 2018.
- 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.
Based on Beaconlight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.